1 Erratum to: Am J Cardiovasc Drugs DOI 10.1007/s40256-015-0113-8
Key points, second sentence which previously read:
The benefits of bivalirudin were seen mainly in DM patients undergoing effective PCI.
Should read:
The benefits of bivalirudin were seen mainly in DM patients undergoing elective PCI.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s40256-015-0113-8.
Rights and permissions
About this article
Cite this article
Ibebuogu, U.N., Bolorunduro, O., Giri, S. et al. Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. Am J Cardiovasc Drugs 15, 287 (2015). https://doi.org/10.1007/s40256-015-0118-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40256-015-0118-3